+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Transdermal Patches Market by Product (Matrix, Multi-layer Drug-in-Adhesive, Reservoir), Type (Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Fentanyl Transdermal Patch), Technology, Application, Distribution Channel, End Users - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5519528
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transdermal Patches Market grew from USD 8.57 billion in 2023 to USD 9.89 billion in 2024. It is expected to continue growing at a CAGR of 16.40%, reaching USD 24.84 billion by 2030.

These patches are used for a range of purposes, including nicotine cessation, hormone replacement therapy, pain management, and the administration of anti-hypertensive, anti-inflammatory, and contraceptive medications. The growing aging population facing difficulty in oral medication administration may benefit from the ease of use of transdermal patches. The prevalence of chronic diseases and the rising preference for non-invasive drug delivery methods are raising the need for transdermal patches. However, high costs and limitations associated with transdermal patches can impede end-user adoption. Moreover, ongoing R&D to develop innovative drug delivery systems and enhance the effectiveness and range of available transdermal drug delivery systems are expected to encourage their use to treat chronic conditions globally.

Regional Insights

The transdermal patches market is developing in the Americas owing to the advanced healthcare infrastructure, high healthcare expenditure, increasing prevalence of chronic diseases, and the presence of key market players actively involved in developing new transdermal technologies. Favorable regulatory policies and a strong focus on research and development activities contribute to the transdermal patch market's growth in the Americas. Europe is another crucial market for transdermal patches owing to the increasing geriatric population with chronic conditions requiring convenient medication delivery options such as transdermal patches. Governments and healthcare organizations across Europe have been advocating for cost-effective treatment methods consistent with an at-home healthcare trend, significantly driving the need for self-administered therapies such as transdermal patches. Health infrastructure and economic developments are improving the accessibility and adoption of transdermal patches by end-users in the Middle East and Africa region. The Asia-Pacific region is emerging as the fastest-growing market for transdermal patches due to increasing healthcare awareness and the growing need for chronic disease management. Improvements in healthcare infrastructure and rising income levels are forecasted to support the growth of the transdermal patches market in the APAC region.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Transdermal Patches Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increased use of transdermal patches to treat chronic conditions worldwide
  • Rising preference for controlled drug release and non-invasive drug delivery solutions
  • Growing number of government approvals for transdermal patches

Market Restraints

  • High costs associated with transdermal patches

Market Opportunities

  • Ongoing research and development for advanced and highly efficient transdermal drug delivery patches
  • Emerging advances in the formulation and manufacturing of transdermal patches

Market Challenges

  • Limitations associated with transdermal drugs along with product recalls

Market Segmentation Analysis

  • Product: Significant penetration of Multi-layer Drug-in-Adhesive patches
  • Type: Extensive requirement for nicotine transdermal patches
  • Technology: Utilization of chemical enhancers to improve transdermal patch efficacy
  • Application: Expanding use of transdermal patches for hormonal therapy
  • Distribution Channel: Proliferation of transdermal patches on eCommerce platforms
  • End Users: Increasing prescription of transdermal patches in hospitals

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Transdermal Patches Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Transdermal Patches Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

DifGen Pharmaceuticals Launches A Second Product - Buprenorphine Transdermal System From Its U.S. Manufacturing Site Aveva Drug Delivery Systems; Expanding Its Portfolio Of Manufacturing & Marketing U.S. Made Transdermal Patches And Sublingual Films

DifGen Pharmaceuticals LLC announced the successful launch of their second complex transdermal product in the U.S. market. This achievement comes within seven months of their first acquisition, marking another significant milestone for the company. With the launch, DifGen aims to establish and expand a local U.S. manufacturing base.

Luye Pharma Ltd Launches New Alzheimer's Treatment In The UK

Luye Pharma Ltd, a subsidiary of Luye Pharma Group, introduced Zeyzelf twice-weekly rivastigmine transdermal patches for the symptomatic treatment of mild to moderately severe Alzheimer's dementia. This launch aligns with Luye Pharma Ltd's commitment to specialize in treatments for CNS diseases, and it exemplifies their vision of offering cost-effective and innovative medications to the UK NHS.

Corsair Pharma Announces USD 23 Million Series B Financing to Advance Clinical Trials in Pulmonary Arterial Hypertension

Corsair Pharma secured USD 23 million in Series B financing to advance clinical trials in the field of Pulmonary Arterial Hypertension (PAH). The funding is utilized to further develop their Transdermal Patches for the treatment of PAH and to establish additional clinical trials. This significant investment highlights Corsair Pharma's long-term commitment to provide innovative and effective treatments for patients suffering from PAH.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Transdermal Patches Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Transdermal Patches Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AdhexPharma SAS, ALVOGEN, Amneal Pharmaceuticals, Inc., Bayer AG, BioNxt Solutions Inc., Bliss GVS Pharma Ltd., Boehringer Ingelheim International GmbH, Corium, Inc., Corsair Pharma, Inc., DifGen Pharmaceuticals LLC, Endo International plc, Gedeon Richter Plc, GlaxoSmithKline Plc, Icure Pharmaceutical Inc., Johnson & Johnson Services, Inc., LAVIPHARM GROUP HOLDING S.A., Luye Pharma Group Ltd, Medherant Limited, Nitto Denko Corporation, Novartis AG, Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc., Nutriband Inc, Perrigo Company plc, ProSolus, Inc., Purdue Pharma L.P., Sparsha Pharma International Pvt Ltd, Tapemark by LTS Lohmann Therapie-Systeme AG, Teikoku Seiyaku Co., Ltd., Tesa SE by Beiersdorf AG, Teva Pharmaceutical Industries Ltd., UCB S.A., Viatris Inc., and Zydus Group.

Market Segmentation & Coverage

This research report categorizes the Transdermal Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Matrix
  • Multi-layer Drug-in-Adhesive
  • Reservoir
  • Single-layer Drug-in-Adhesive

Type

  • Buprenorphine Transdermal Patch
  • Clonidine Transdermal Patch
  • Fentanyl Transdermal Patch
  • Nicotine Transdermal Patch
  • Oxybutynin Transdermal Patch

Technology

  • Chemical Enhancers
  • Electric Current
  • Mechanical Arrays
  • Thermal Ablation

Application

  • Hormonal Therapy
  • Overactive Bladder
  • Pain Relief
  • Smoking Reduction & Cessation Aid

Distribution Channel

  • Offline
  • Online

End Users

  • Clinics
  • Home Care Settings
  • Hospitals

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased use of transdermal patches to treat chronic conditions worldwide
5.1.1.2. Rising preference for controlled drug release and non-invasive drug delivery solutions
5.1.1.3. Growing number of government approvals for transdermal patches
5.1.2. Restraints
5.1.2.1. High costs associated with transdermal patches
5.1.3. Opportunities
5.1.3.1. Ongoing research and development for advanced and highly efficient transdermal drug delivery patches
5.1.3.2. Emerging advances in the formulation and manufacturing of transdermal patches
5.1.4. Challenges
5.1.4.1. Limitations associated with transdermal drugs along with product recalls
5.2. Market Segmentation Analysis
5.2.1. Product: Significant penetration of Multi-layer Drug-in-Adhesive patches
5.2.2. Type: Extensive requirement for nicotine transdermal patches
5.2.3. Technology: Utilization of chemical enhancers to improve transdermal patch efficacy
5.2.4. Application: Expanding use of transdermal patches for hormonal therapy
5.2.5. Distribution Channel: Proliferation of transdermal patches on eCommerce platforms
5.2.6. End Users: Increasing prescription of transdermal patches in hospitals
5.3. Market Trend Analysis
5.3.1. Supportive government approval landscape for transdermal patches in the Americas
5.3.2. Growing prevalence of chronic pain and diabetes propelling the growth of transdermal patches in the APAC region
5.3.3. Improving healthcare infrastructure to increase access of innovative transdermal patches in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Transdermal Patches Market, by Product
6.1. Introduction
6.2. Matrix
6.3. Multi-layer Drug-in-Adhesive
6.4. Reservoir
6.5. Single-layer Drug-in-Adhesive
7. Transdermal Patches Market, by Type
7.1. Introduction
7.2. Buprenorphine Transdermal Patch
7.3. Clonidine Transdermal Patch
7.4. Fentanyl Transdermal Patch
7.5. Nicotine Transdermal Patch
7.6. Oxybutynin Transdermal Patch
8. Transdermal Patches Market, by Technology
8.1. Introduction
8.2. Chemical Enhancers
8.3. Electric Current
8.4. Mechanical Arrays
8.5. Thermal Ablation
9. Transdermal Patches Market, by Application
9.1. Introduction
9.2. Hormonal Therapy
9.3. Overactive Bladder
9.4. Pain Relief
9.5. Smoking Reduction & Cessation Aid
10. Transdermal Patches Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.3. Online
11. Transdermal Patches Market, by End Users
11.1. Introduction
11.2. Clinics
11.3. Home Care Settings
11.4. Hospitals
12. Americas Transdermal Patches Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Transdermal Patches Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Transdermal Patches Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. DifGen Pharmaceuticals Launches A Second Product - Buprenorphine Transdermal System From Its U.S. Manufacturing Site Aveva Drug Delivery Systems; Expanding Its Portfolio Of Manufacturing & Marketing U.S. Made Transdermal Patches And Sublingual Films
15.3.2. Luye Pharma Ltd Launches New Alzheimer's Treatment In The UK
15.3.3. Corsair Pharma Announces USD 23 Million Series B Financing to Advance Clinical Trials in Pulmonary Arterial Hypertension
15.3.4. Vaxess Raises USD 9 Million to Accelerate mRNA Vaccine Patch Development
15.3.5. Almirall Acquires Rights To Distribute Alzheimer’s Treatment In Spain For An Initial EUR 45 Million
15.3.6. Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY in Multiple Markets Across Asia
15.3.7. Dexmedetomidine Transdermal Patch Fast Tracked for Postop Pain Management
15.3.8. LTS Completes its Entry into Large Molecule Drug Delivery with the Acquisition of the Sorrel Wearable Injection Device Business
15.3.9. BioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson’s Disease
15.3.10. Bionxt Signs Clinical Study Agreement and Commences Manufacture of Clinical Samples for Study of Transdermal Rotigotine Patch for Parkinson’s Disease
15.3.11. LTS Lohmann Leads Investment in Needle-Free Delivery Specialist
15.3.12. The Addition of Tesa Labtec GmbH Marks a Cornerstone in AdhexPharma’s Growth Path
16. Competitive Portfolio
16.1. Key Company Profiles
16.2. Key Product Portfolio
List of Figures
FIGURE 1. TRANSDERMAL PATCHES MARKET RESEARCH PROCESS
FIGURE 2. TRANSDERMAL PATCHES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TRANSDERMAL PATCHES MARKET DYNAMICS
FIGURE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
FIGURE 18. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 22. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 28. TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. TRANSDERMAL PATCHES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY RESERVOIR, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY RESERVOIR, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE TRANSDERMAL PATCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE TRANSDERMAL PATCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE TRANSDERMAL PATCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE TRANSDERMAL PATCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL TRANSDERMAL PATCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL TRANSDERMAL PATCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE TRANSDERMAL PATCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE TRANSDERMAL PATCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OXYBUTYNIN TRANSDERMAL PATCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OXYBUTYNIN TRANSDERMAL PATCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CHEMICAL ENHANCERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CHEMICAL ENHANCERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ELECTRIC CURRENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ELECTRIC CURRENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MECHANICAL ARRAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MECHANICAL ARRAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN RELIEF, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING REDUCTION & CESSATION AID, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING REDUCTION & CESSATION AID, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OFFLINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 86. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 87. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 88. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 91. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 92. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 93. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 94. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 95. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 99. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 100. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 101. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 104. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 106. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 107. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 110. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 111. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 112. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 113. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 116. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 118. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 119. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 122. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 123. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 124. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 125. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 126. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 127. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 128. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 129. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 130. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 131. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 134. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 135. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 136. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 137. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 138. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 140. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 142. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 144. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 148. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 150. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 152. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 153. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 154. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 155. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 156. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 157. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 158. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 159. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 162. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 163. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 164. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 165. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 166. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 167. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 168. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 169. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 170. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 171. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 174. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 175. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 176. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 177. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 178. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 179. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 180. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 181. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 182. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 183. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 186. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 187. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 188. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 189. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 190. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 191. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 192. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 193. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 194. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 195. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 198. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 199. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 200. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 201. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 202. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 203. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 204. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 205. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 206. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 207. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 210. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 211. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 212. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 213. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 214. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 215. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 216. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 217. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 218. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 219. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 222. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 223. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 224. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 225. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 226. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 227. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 228. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 229. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 230. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 231. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 232. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 233. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 234. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 235. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 236. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 237. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 238. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 239. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 240. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 241. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 242. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 243. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 246. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 247. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 248. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 249. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 250. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 251. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 252. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 253. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 254. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 255. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 256. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 257. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 258. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 259. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 260. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 261. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 262. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 263. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 264. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 265. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 266. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 267. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 270. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 271. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 272. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 273. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 274. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 275. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 276. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 277. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 278. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 279. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 280. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 281. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 282. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 283. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 284. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 285. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 286. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 287. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 288. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 289. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 290. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 291. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 292. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 293. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 294. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 295. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 296. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 311. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 312. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 313. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 314. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 315. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 316. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 317. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 320. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 321. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 322. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 323. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 324. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 325. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 326. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 327. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 328. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 329. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 330. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 331. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 332. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 333. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 334. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 335. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 336. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 337. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 338. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 339. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 340. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 341. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 342. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 343. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 344. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 345. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 346. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 347. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 348. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PRODU

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • AdhexPharma SAS
  • ALVOGEN
  • Amneal Pharmaceuticals, Inc.
  • Bayer AG
  • BioNxt Solutions Inc.
  • Bliss GVS Pharma Ltd.
  • Boehringer Ingelheim International GmbH
  • Corium, Inc.
  • Corsair Pharma, Inc.
  • DifGen Pharmaceuticals LLC
  • Endo International plc
  • Gedeon Richter Plc
  • GlaxoSmithKline Plc
  • Icure Pharmaceutical Inc.
  • Johnson & Johnson Services, Inc.
  • LAVIPHARM GROUP HOLDING S.A.
  • Luye Pharma Group Ltd
  • Medherant Limited
  • Nitto Denko Corporation
  • Novartis AG
  • Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.
  • Nutriband Inc
  • Perrigo Company plc
  • ProSolus, Inc.
  • Purdue Pharma L.P.
  • Sparsha Pharma International Pvt Ltd
  • Tapemark by LTS Lohmann Therapie-Systeme AG
  • Teikoku Seiyaku Co., Ltd.
  • Tesa SE by Beiersdorf AG
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A.
  • Viatris Inc.
  • Zydus Group

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 9.89 Billion
Forecasted Market Value ( USD ) by 2030 $ 24.84 Billion
Compound Annual Growth Rate16.4%
Regions CoveredGlobal

Related Topics

Related Reports

Global Transdermal Drug Delivery System Market by Type (Transdermal Patches, Transdermal Semisolids), Application (Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications), End User - Forecast 2024-2030 - Product Image

Global Transdermal Drug Delivery System Market by Type (Transdermal Patches, Transdermal Semisolids), Application (Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications), End User - Forecast 2024-2030

  • Report
  • 193 Pages
  • Global
From
Global Transdermal Patches Market by Type (Drug-in-adhesives, Matrix, Reservoir Membrane), Adhesive (Acrylic, Silicone, Hydrogel), Application (Pain, CVS, Hormonal), Distribution Channel (Pharmacy (Retail Online, Hospital)), End-user, and Region - Forecast to 2029 - Product Image

Global Transdermal Patches Market by Type (Drug-in-adhesives, Matrix, Reservoir Membrane), Adhesive (Acrylic, Silicone, Hydrogel), Application (Pain, CVS, Hormonal), Distribution Channel (Pharmacy (Retail Online, Hospital)), End-user, and Region - Forecast to 2029

  • Report
  • 282 Pages
  • Global
From
Global Transdermal Patches Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Global Transdermal Patches Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 153 Pages
  • Global
From
Global Transdermal Skin Patches Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Global Transdermal Skin Patches Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 155 Pages
  • Global
From
Global Transdermal Patches Market Size, Share & Industry Trends Analysis Report By End User, By Distribution Channel, By Adhesive Type (Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives and Others), By Patch Type, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Transdermal Patches Market Size, Share & Industry Trends Analysis Report By End User, By Distribution Channel, By Adhesive Type (Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives and Others), By Patch Type, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 632 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.